Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    1 1 1
    Czechia France Germany Greece Italy The Netherlands +1
  • Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    1 1 1 1
    Belgium Croatia Greece Hungary Italy Poland
  • Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Norway Spain +1
  • Study on Personalized Maintenance Therapy with Rituximab and Corticosteroids for Patients with Pemphigus

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Germany Portugal
  • Study on the Effects of Rituximab and Cyclophosphamide in Patients with ANCA Vasculitis

    Recruiting

    1 1 1 1
    The Netherlands
  • Study on Treating Postoperative Anemia in Older Cardiac Surgery Patients with Ferric Derisomaltose and Sodium Chloride

    Recruiting

    1 1 1
    Investigated diseases:
    The Netherlands
  • Study on Using Fluorescein Sodium to Identify Inflammation in Crohn’s Disease Patients During Ileal Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Preventing Bleeding in Children with Severe von Willebrand Disease Using Vonicog Alfa and Octocog Alfa

    Recruiting

    1 1 1 1
    Investigated drugs:
    France Ireland Italy Spain
  • Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    1 1
    Investigated drugs:
    Germany Hungary Poland Romania Spain